Phase 1 data confirms SAB-142 does not cause serum sickness and has low/no immunogenicity at any dose and in all cohorts, including redosed ...

Innovation in ophthalmology is often measured by what reaches the clinic—but the path to those breakthroughs begins much ...

The "Human Factors and Usability Engineering in the Development of Drug Delivery Products Training Course (Feb 11th - Feb 12th, 2026)" training has been added to ResearchAndMarkets.com's offering.

In this exclusive MedPage Today video, Specht is joined via Zoom by study co-lead, Heather Jacene, MD, of Brigham and Women's ...

A new study examining 218 mental health professionals in Spain reveals that recovery-oriented training doesn't impact ...

A Mumbai-based study has found widespread adoption of AI chatbots among MBBS students, with 86 percent using them for ...

A new international online survey published in the Journal of Affective Disorders gives voice to the lived experiences of ...

The study shows that ChatGPT usage among healthcare students in Saudi Arabia is no longer experimental or marginal. Nearly ...

Detailed price information for Medicus Pharma Ltd (MDCX-Q) from The Globe and Mail including charting and trades.

At two years of follow-up, fewer than 20% of evaluable patients developed grade 2 or higher radiation-related toxic effects, ...

The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...

Money troubles associated with 60% higher death risk in study using AI to measure heart aging. Financial strain topped nine social factors.